P103-0886 Screening compound: 2-{[3-(5-methyl-1,2,4-oxadiazol-3-yl)pyridin-2-yl]sulfanyl}-N-[4-(morpholin-4-yl)phenyl]acetamide

P103-0886 Screening compound: 2-{[3-(5-methyl-1,2,4-oxadiazol-3-yl)pyridin-2-yl]sulfanyl}-N-[4-(morpholin-4-yl)phenyl]acetamide
P103-0886 Screening compound: 2-{[3-(5-methyl-1,2,4-oxadiazol-3-yl)pyridin-2-yl]sulfanyl}-N-[4-(morpholin-4-yl)phenyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P103-0886
2-{[3-(5-methyl-1,2,4-oxadiazol-3-yl)pyridin-2-yl]sulfanyl}-N-[4-(morpholin-4-yl)phenyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P103-0886

Molecular Formula

C20H21N5O3S (C20 H21 N5 O3 S)

Compound Name

2-{[3-(5-methyl-1,2,4-oxadiazol-3-yl)pyridin-2-yl]sulfanyl}-N-[4-(morpholin-4-yl)phenyl]acetamide

IUPAC name

2-{[3-(5-methyl-124-oxadiazol-3-yl)pyridin-2-yl]sulfanyl}-N-[4-(morpholin-4-yl)phenyl]acetamide

SMILES

Cc1nc(-c2cccnc2SCC(Nc(cc2)ccc2N2CCOCC2)=O)no1

InChI

InChI=1S/C20H21N5O3S/c1-14-22-19(24-28-14)17-3-2-8-21-20(17)29-13-18(26)23-15-4-6-16(7-5-15)25-9-11-27-12-10-25/h2-8H,9-13H2,1H3,(H,23,26)

InChI Key

UCSNNYICGOHJMH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29025108

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.434

Distribution Coefficient, logD

2.433

Water Solubility, LogSw

-3.02

Polar Surface Area

74.562

Acid Dissociation Constant (pKa)

12.66

Base Dissociation Constant (pKb)

4.79

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

P103-0886 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with P103-0886 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P103-0886?
Check Price and Availability of P103-0886, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P103-0886 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P103-0886
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P103-0886
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P103-0886 available by request